RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,189 | -24.5% | 18,693 | -9.8% | 0.00% | – |
| Q2 2023 | $26,725 | -6.5% | 20,717 | -4.4% | 0.00% | – |
| Q1 2023 | $28,591 | -12.3% | 21,660 | 0.0% | 0.00% | – |
| Q4 2022 | $32,598 | -57.1% | 21,660 | -66.2% | 0.00% | – |
| Q3 2022 | $76,000 | +7.0% | 64,114 | +2.3% | 0.00% | – |
| Q2 2022 | $71,000 | -64.7% | 62,642 | -6.8% | 0.00% | – |
| Q1 2022 | $201,000 | +12.3% | 67,224 | +0.0% | 0.00% | – |
| Q4 2021 | $179,000 | -21.8% | 67,210 | +6.6% | 0.00% | – |
| Q3 2021 | $229,000 | +77.5% | 63,054 | +112.6% | 0.00% | – |
| Q2 2021 | $129,000 | +35.8% | 29,657 | +7.2% | 0.00% | – |
| Q1 2021 | $95,000 | +14.5% | 27,663 | +16.3% | 0.00% | – |
| Q4 2020 | $83,000 | +45.6% | 23,796 | 0.0% | 0.00% | – |
| Q3 2020 | $57,000 | 0.0% | 23,796 | -23.6% | 0.00% | – |
| Q2 2020 | $57,000 | +29.5% | 31,149 | +10.6% | 0.00% | – |
| Q1 2020 | $44,000 | -43.6% | 28,153 | -22.1% | 0.00% | – |
| Q4 2019 | $78,000 | +36.8% | 36,143 | +19.7% | 0.00% | – |
| Q3 2019 | $57,000 | -27.8% | 30,192 | 0.0% | 0.00% | – |
| Q2 2019 | $79,000 | +1.3% | 30,192 | 0.0% | 0.00% | – |
| Q1 2019 | $78,000 | +13.0% | 30,192 | 0.0% | 0.00% | – |
| Q4 2018 | $69,000 | -22.5% | 30,192 | +9.0% | 0.00% | – |
| Q3 2018 | $89,000 | +12.7% | 27,692 | 0.0% | 0.00% | – |
| Q2 2018 | $79,000 | -15.1% | 27,692 | +5.4% | 0.00% | – |
| Q1 2018 | $93,000 | -32.1% | 26,273 | -26.3% | 0.00% | – |
| Q4 2017 | $137,000 | +80.3% | 35,649 | +16.5% | 0.00% | – |
| Q3 2017 | $76,000 | -9.5% | 30,605 | 0.0% | 0.00% | – |
| Q2 2017 | $84,000 | -4.5% | 30,605 | +15.8% | 0.00% | – |
| Q1 2017 | $88,000 | +33.3% | 26,431 | -3.8% | 0.00% | – |
| Q4 2016 | $66,000 | +22.2% | 27,485 | +79.6% | 0.00% | – |
| Q3 2016 | $54,000 | +45.9% | 15,302 | -11.6% | 0.00% | – |
| Q2 2016 | $37,000 | +5.7% | 17,309 | 0.0% | 0.00% | – |
| Q1 2016 | $35,000 | -34.0% | 17,309 | 0.0% | 0.00% | – |
| Q4 2015 | $53,000 | +26.2% | 17,309 | 0.0% | 0.00% | – |
| Q3 2015 | $42,000 | -19.2% | 17,309 | 0.0% | 0.00% | – |
| Q2 2015 | $52,000 | -16.1% | 17,309 | 0.0% | 0.00% | – |
| Q1 2015 | $62,000 | +55.0% | 17,309 | 0.0% | 0.00% | – |
| Q4 2014 | $40,000 | +14.3% | 17,309 | 0.0% | 0.00% | – |
| Q3 2014 | $35,000 | – | 17,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |